TSHA
Taysha Gene Therapies, Inc. Common Stock
$2.19
-7.24%
-0.17
Notify me if price changes either direction
Buy TSHA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
465.2M
Enterprise value
511M
Trailing PE
-2.208333214124
Forward PE
-5.404762
PEG Ratio
-5.404762
Enterprise to EBITDA
-6.297
Enterprise to revenue
51.538
Price to book MRQ
6.8373494
Price to sales TTM
46.92089
Financials
Fiscal Year Ends
2023-12-31
Most Recent Quarter (MRQ)
2024-06-30
Revenue (TTM)
9.9M
EBITDA
-81154000
Diluted EPS TTM
-0.5
Total Cash (MRQ)
157.7M
Current ratio (MRQ)
5.507
Operating Cash Flow (TTM)
-110768000
TSHA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
In the last 0 months
November 2024
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Unlock All Transactions As They Come
Upgrade now to access all U.S. politician trades for this and other stocks. Get the latest signals as they come.
